Company / PP&E (Net)
enGene Holdings Inc. PP&E (Net) History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$2.5M
FY2025
5-year range
$387.0K / $2.5M
FY2022-FY2025
Trend
+111.9%
vs FY2024
Sector context
#132 of 197
Health Care
What the data says
At $2M, enGene Holdings Inc.'s pp&e (net) ranks #132 of 197 in the Health Care sector. PP&E (Net) has increased for 3 consecutive years, from $387,000 in FY2022 to $2M in FY2025.
Based on SEC 10-K filings.
$2M in FY2025 with a 3-year CAGR of +85.7%.
Improved from $589,000 to $2M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +85.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#132 of 197 in Health CareTop 67% of 197This company $2.5M Sector average $773.5M
▼
-99.7% below sector average
Key checks
Key Insights
- enGene Holdings Inc.'s pp&e (net) has grown for 3 consecutive years.
- 3-year CAGR of +85.7%, indicating consistent growth.
- In FY2025, pp&e (net) increased 111.9% year-over-year.
- Ranks #132 out of 197 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.5M | +111.9% |
| FY2024 | $1.2M | +98.5% |
| FY2023 | $589.0K | +52.2% |
| FY2022 | $387.0K | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026